Ads
related to: hemophilia a- Hemophilia's Impact
Learn More About Common Hemophilia
Symptoms And How It Can Impact You.
- Hemophilia Resources
Access Guides And Resources For
People With Hemophilia A or B.
- Sign Up to Stay Updated
Learn More About Research And
Developments In Hemophilia.
- What is Rebalancing?
Learn More About The
Rebalancing Approach In Hemophilia.
- Hemophilia's Impact
Search results
Novo Nordisk's (NVO) Haemophilia A Study Meets Safety Endpoint
Zacks via Yahoo Finance· 2 years agoNovo Nordisk's (NVO) phase I & II FRONTIER1 dose-escalation study investigating Mim8 for treating...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
Zacks via Yahoo Finance· 8 months agoBaudax Bio BXRX announced that the FDA has granted the Orphan Drug designation to its...
Pfizer's (PFE) Hemophilia Candidate BLA Gets FDA Acceptance
Zacks via Yahoo Finance· 6 months agoThe FDA decision on Pfizer's (PFE) BLA for marstacimab for hemophilia A and B is expected in the...
Charles River (CRL) to Create New Gene Therapy for Hemophilia A
Zacks via Yahoo Finance· 2 years agoCharles River Laboratories International, Inc. CRL recently inked an agreement with ASC...
US FDA approves BioMarin's gene therapy for hemophilia A
Reuters via Yahoo News· 11 months ago(Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene...
BioMarin (BMRN) Refiles BLA With FDA for Hemophilia Gene Therapy
Zacks via Yahoo Finance· 2 years agoIf approved, BioMarin's (BMRN) valoctocogene roxaparvovec will be the first gene therapy for...
BioMarin (BMRN) Gets CHMP Nod for Hemophilia Drug Roctavian
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) receives a positive CHMP opinion for Roctavian, its gene therapy for treating adults...
Sanofi: Phase-3 study on Hemophilia A treatment met primary endpoint
Reuters via Yahoo News· 1 year agoA phase-3 study on the safety and efficacy of its ALTUVIIIO Hemophilia A treatment used for children...
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
